Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Dermatology Reports
Published in: Current Dermatology Reports 4/2014

01-12-2014 | Pediatrics (R Sidbury, Section Editor)

Alternative Medicine in Pediatric Dermatology: What Is the Evidence?

Authors: Mark A. Strom, Peter A. Lio

Published in: Current Dermatology Reports | Issue 4/2014

Login to get access

Abstract

Many patients seek alternative and complementary therapies, particularly when diseases are incurable or when conventional treatments have undesirable side effects that are real or perceived. This article reviews some selective evidence behind alternative therapies utilized in the treatment of three common diseases in pediatric dermatology: atopic dermatitis, acne vulgaris, and cutaneous warts. While some show promise, the treatments discussed vary greatly in the quality and quantity of supporting evidence and should be carefully considered when advising patients on their use.
Literature
1.
Jensen P. Use of alternative medicine by patients with atopic dermatitis and psoriasis. Acta Derm Venereol. 1990;70(5):421–4.PubMed
2.
Simpson EL, Basco M, Hanifin J. A cross-sectional survey of complementary and alternative medicine use in patients with atopic dermatitis. Am J Contact Dermat. 2003;14(3):144–7.PubMed
3.
Aguiar Júnior N dos R, Costa IMC. The use of alternative or complementary medicine for children with atopic dermatitis. An Bras Dermatol. 2011;86(1):167–8
4.•
Kabashima K. New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity. J Dermatol Sci. 2013;70(1):3–11. A very clearly written summary of the most cutting-edge thinking about the multi-factorial pathogenesis of atopic dermatitis.PubMedCrossRef
5.••
Schneider L, Tilles S, Lio P, et al. Atopic dermatitis: a practice parameter update 2012. J Allergy Clin Immunol. 2013;131(2):295–9.e1-27. A detailed review of the evidence for diagnosis and treatment of atopic dermatitis, with discussion of some non-pharmacologic therapies as well.PubMedCrossRef
6.
Kojima R, Fujiwara T, Matsuda A, et al. Factors associated with steroid phobia in caregivers of children with atopic dermatitis. Pediatr Dermatol. 2013;30(1):29–35.PubMedCrossRef
7.
Prottey C, Hartop PJ, Press M. Correction of the cutaneous manifestations of essential fatty acid deficiency in man by application of sunflower-seed oil to the skin. J Invest Dermatol. 1975;64(4):228–34.PubMedCrossRef
8.
Jamieson GS, Baughman WF. The chemical composition of sunflower-seed oil. J Am Chem Soc. 1922;44(12):2952–7.CrossRef
9.
Elias PM, Brown BE, Ziboh VA. The permeability barrier in essential fatty acid deficiency: evidence for a direct role for linoleic acid in barrier function. J Invest Dermatol. 1980;74(4):230–3.PubMedCrossRef
10.
Eichenfield LF, McCollum A, Msika P. The benefits of sunflower oleodistillate (SOD) in pediatric dermatology. Pediatr Dermatol. 2009;26(6):669–75.PubMedCrossRef
11.
Yessoufou a, Wahli W. Multifaceted roles of peroxisome proliferator-activated receptors (PPARs) at the cellular and whole organism levels. Swiss Med Wkly. 2010;140(September):w13071.
12.
Rivier M, Castiel I, Safonova I. Peroxisome proliferator-activated receptor-α enhances lipid metabolism in a skin equivalent model. J Investig. 2000;114(4):681–7.
13.
Msika P, De Belilovsky C, Piccardi N, Chebassier N, Baudouin C, Chadoutaud B. New emollient with topical corticosteroid-sparing effect in treatment of childhood atopic dermatitis: SCORAD and quality of life improvement. Pediatr Dermatol. 2008;25(6):606–12.PubMedCrossRef
14.
Darmstadt GL, Saha SK, Ahmed a SMNU, et al. Effect of topical treatment with skin barrier-enhancing emollients on nosocomial infections in preterm infants in Bangladesh: a randomised controlled trial. Lancet. 2005;365(9464):1039–45.PubMedCrossRef
15.
Darmstadt GL, Saha SK, SMNU A a, et al. Effect of skin barrier therapy on neonatal mortality rates in preterm infants in Bangladesh: a randomized, controlled, clinical trial. Pediatrics. 2008;121(3):522–9.PubMedCrossRef
16.
LeFevre A, Shillcutt SD, Saha SK, et al. Cost-effectiveness of skin-barrier-enhancing emollients among preterm infants in Bangladesh. Bull World Health Organ. 2010;88(2):104–12.PubMedCentralPubMedCrossRef
17.
Gong J, Lin L, Lin T, Hao F. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial. Br J Dermatol. 2006;155(4):680–7.PubMedCrossRef
18.
Park H-Y, Kim C-R, Huh I-S, et al. Staphylococcus aureus colonization in acute and chronic skin lesions of patients with atopic dermatitis. Ann Dermatol. 2013;25(4):410–6.PubMedCentralPubMedCrossRef
19.
Leung DY, Harbeck R, Bina P, et al. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens. J Clin Invest. 1993;92(3):1374–80.PubMedCentralPubMedCrossRef
20.
Nakamura Y, Oscherwitz J, Cease KB, et al. Staphylococcus δ-toxin induces allergic skin disease by activating mast cells. Nature. 2013;503(7476):397–401.PubMedCentralPubMedCrossRef
21.
Verallo-Rowell VM, Dillague KM, Syah-Tjundawan BS. Novel antibacterial and emollient effects of coconut and virgin olive oils in adult atopic dermatitis. Dermat Contact, Atopic, Occup Drug. 2008;19(6):308–15.
22.•
Kong HH, Oh J, Deming C, et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res. 2012;22(5):850–9. Exciting data and hypotheses around the role of the microbiome in atopic dermatitis.PubMedCentralPubMedCrossRef
23.
Ismail IH, Oppedisano F, Joseph SJ, et al. Reduced gut microbial diversity in early life is associated with later development of eczema but not atopy in high-risk infants. Pediatr Allergy Immunol. 2012;23(7):674–81.PubMedCrossRef
24.
Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet. 2001;357(9262):1076–9.PubMedCrossRef
25.
Kopp MV, Hennemuth I, Heinzmann A, Urbanek R. Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics. 2008;121(4):e850–6.PubMedCrossRef
26.
Van der Aa LB, Heymans HS A, van Aalderen WMC, Sprikkelman AB. Probiotics and prebiotics in atopic dermatitis: review of the theoretical background and clinical evidence. Pediatr Allergy Immunol. 2010;21(2 Pt 2):e355–67.PubMed
27.
Pelucchi C, Chatenoud L, Turati F, et al. Probiotics supplementation during pregnancy or infancy for the prevention of atopic dermatitis: a meta-analysis. Epidemiology. 2012;23(3):402–14.PubMedCrossRef
28.
King RM, Wilson GV. Use of a diary technique to investigate psychosomatic relations in atopic dermatitis. J Psychosom Res. 1991;35(6):697–706.PubMedCrossRef
29.
Field T, Morrow C, Valdeon C, Larson S, Kuhn C, Schanberg S. Massage reduces anxiety in child and adolescent psychiatric patients. J Am Acad Child Adolesc Psychiatry. 1992;31(1):125–31.PubMedCrossRef
30.
Schachner L, Field T, Hernandez-Reif M, Duarte AM, Krasnegor J. Atopic dermatitis symptoms decreased in children following massage therapy. Pediatr Dermatol. 1998;15(5):390–5.PubMedCrossRef
31.
Thiboutot D, Gollnick H, Bettoli V, et al. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Psychosom Res. 2009;60(5 Suppl):S1–S50.
32.•
Lee KC, Lio PA. Evidence-based recommendations for the diagnosis and treatment of paediatric acne. Arch Dis Child Educ Pract Ed. 2014;99(4):135–7. An efficient overview of the most recent evidence-based acne guidelines for pediatrics.PubMedCrossRef
33.
Carson CF, Hammer KA, Riley TV. Melaleuca alternifolia (tea tree) oil: a review of antimicrobial and other medicinal properties. Clin Microbiol Rev. 2006;19(1):50–62.PubMedCentralPubMedCrossRef
34.
Enshaieh S, Jooya A, Siadat AH, Iraji F. The efficacy of 5 % topical tea tree oil gel in mild to moderate acne vulgaris: a randomized, double-blind placebo-controlled study. Indian J Dermatol Venereol Leprol. 2007;73(1):22–5.PubMedCrossRef
35.
Bassett IB, Pannowitz DL, Barnetson RS. A comparative study of tea-tree oil versus benzoylperoxide in the treatment of acne. Med J Aust. 1990;153(8):455–8.PubMed
36.
Jack AR, Norris PL, Storrs FJ. Allergic contact dermatitis to plant extracts in cosmetics. Semin Cutan Med Surg. 2013;32(3):140–6.PubMed
37.
Grange PA, Raingeaud J, Calvez V, Dupin N. Nicotinamide inhibits Propionibacterium acnes-induced IL-8 production in keratinocytes through the NF-kappaB and MAPK pathways. J Dermatol Sci. 2009;56(2):106–12.PubMedCrossRef
38.
Niren NM, Torok HM. The Nicomide Improvement in Clinical Outcomes Study (NICOS): results of an 8-week trial. Cutis. 2006;77(1 Suppl):17–28.PubMed
39.
Shalita AR, Smith JG, Parish LC, Sofman MS, Chalker DK. Topical nicotinamide compared with clindamycin gel in the treatment of inflammatory acne vulgaris. Int J Dermatol. 1995;34(6):434–7.PubMedCrossRef
40.
Dreno B, Moyse D, Alirezai M, et al. Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris. Dermatology. 2001;203(2):135–40.PubMedCrossRef
41.
Weimar VM, Puhl SC, Smith WH, TenBroeke JE. Zinc sulfate in acne vulgaris. Arch Dermatol. 1978;114(12):1776–8.PubMedCrossRef
42.
Sardana K, Chugh S, Garg VK. The role of zinc in acne and prevention of resistance: have we missed the “base” effect? Int J Dermatol. 2014;53(1):125–7.PubMedCrossRef
43.
Sardana K, Garg VK. An observational study of methionine-bound zinc with antioxidants for mild to moderate acne vulgaris. Dermatol Ther. 2010;23(4):411–8.PubMedCrossRef
44.
Boull C, Groth D. Update: treatment of cutaneous viral warts in children. Pediatr Dermatol. 2011;28(3):217–29.PubMedCrossRef
45.
Tomson N, Sterling J, Ahmed I, Hague J, Berth-Jones J. Human papillomavirus typing of warts and response to cryotherapy. J Eur Acad Dermatol Venereol. 2011;25(9):1108–11.PubMedCrossRef
46.••
Kwok CS, Gibbs S, Bennett C, Holland R, Abbott R. Topical treatments for cutaneous warts. Cochrane database Syst Rev. 2012;9(9):CD001781. A deep and through review of wart treatments that includes alternatives as well.
47.
Kuropatnicki AK, Szliszka E, Krol W. Historical aspects of propolis research in modern times. Evid Based Complement Alternat Med. 2013;2013:964149.PubMedCentralPubMed
48.
49.
Lazarczyk M, Pons C, Mendoza J-A, Cassonnet P, Jacob Y, Favre M. Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses. J Exp Med. 2008;205(1):35–42.PubMedCentralPubMedCrossRef
50.
Mun J-H, Kim S-H, Jung D-S, et al. Oral zinc sulfate treatment for viral warts: an open-label study. J Dermatol. 2011;38(6):541–5.PubMedCrossRef
51.
Yaghoobi R, Sadighha A, Baktash D. Evaluation of oral zinc sulfate effect on recalcitrant multiple viral warts: a randomized placebo-controlled clinical trial. J Am Acad Dermatol. 2009;60(4):706–8.PubMedCrossRef
52.
Khattar JA, Musharrafieh UM, Tamim H, Hamadeh GN. Topical zinc oxide vs. salicylic acid-lactic acid combination in the treatment of warts. Int J Dermatol. 2007;46(4):427–30.PubMedCrossRef
53.
Lio PA. Commentary on “Topical treatments for cutaneous warts”. Evidence-Based Child Heal A Cochrane Rev J. 2011;6(5):1695–6.CrossRef
54.
Sharquie KE, Khorsheed AA, Al-Nuaimy AA. Topical zinc sulphate solution for treatment of viral warts. Saudi Med J. 2007;28(9):1418–21.PubMed
55.
Hjorth N, Roed-Petersen J. Occupational protein contact dermatitis in food handlers. Contact Dermatitis. 1976;2(1):28–42.PubMedCrossRef
56.
Harris JC, Cottrell SL, Plummer S, Lloyd D. Antimicrobial properties of Allium sativum (garlic). Appl Microbiol Biotechnol. 2001;57(3):282–6.PubMedCrossRef
57.
58.
Dehghani F, Merat A, Panjehshahin MR, Handjani F. Healing effect of garlic extract on warts and corns. Int J Dermatol. 2005;44(7):612–5.PubMedCrossRef
59.
Filobbos G, Chapman T, Gesakis K. Iatrogenic burns from garlic. J Burn Care Res. 2009;33(1):e21.CrossRef
Metadata
Title
Alternative Medicine in Pediatric Dermatology: What Is the Evidence?
Authors
Mark A. Strom
Peter A. Lio
Publication date
01-12-2014
Publisher
Springer US
Published in
Current Dermatology Reports / Issue 4/2014
Electronic ISSN: 2162-4933
DOI
https://doi.org/10.1007/s13671-014-0086-x

Other articles of this Issue 4/2014

Current Dermatology Reports 4/2014 Go to the issue

Pediatrics (R Sidbury, Section Editor)

Diagnostic Imaging and Image-Guided Therapy for Hemangiomas and Vascular Malformations: What the Dermatologist Needs to Know

Pediatrics (R Sidbury, Section Editor)

The Third Chair in the Examination Room: Practical Ethics of Decision-Making for the Pediatric Dermatologist

Pediatrics (R Sidbury, Section Editor)

What’s New in Pediatric Dermatology

Urticaria (P Staubach, Section Editor)

Pathomechanisms of Chronic Spontaneous Urticaria: What Is Known and Up to Date

Pediatrics (R Sidbury, Section Editor)

Pediatric Dermatology Clinical-Pathologic Cases: A Spectrum of Purpuric Disorders of Childhood